Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

BA-BE Studies: SOP for Monitoring Ambient Conditions of Sample Freezers – V 2.0

Posted on By

BA-BE Studies: SOP for Monitoring Ambient Conditions of Sample Freezers – V 2.0

Standard Operating Procedure for Monitoring Ambient Conditions of Sample Freezers in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/076/2025
Supersedes SOP/BA-BE/076/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To establish a consistent and reliable procedure for monitoring the ambient temperature and relative humidity conditions of rooms where -20°C and -70°C sample freezers are installed, thereby ensuring optimal operating conditions and sample integrity in BA/BE studies.

2. Scope

This SOP applies to all areas within the clinical site or laboratory where biological sample freezers used in BA/BE studies are located and ambient condition monitoring is required.

3. Responsibilities

  • Facility Maintenance Staff: Responsible for maintaining HVAC systems and reporting any anomalies.
  • Lab Technician: Records daily temperature and humidity values.
  • QA Officer: Reviews logs periodically and ensures compliance during audits.
See also  BA-BE Studies: SOP for Setting Up eTMF (Electronic Trial Master File) - V 2.0

4. Accountability

The Facility Manager is accountable for ensuring ambient conditions are monitored and maintained within the specified limits and that proper documentation is retained.

5. Procedure

5.1 Installation and Calibration of Thermo-Hygrometers

  1. Install validated and calibrated digital thermo-hygrometers in each freezer room.
  2. Place sensors at a height of approximately 1.5 meters from the floor, away from direct vents and heat sources.
  3. Calibrate instruments every 6 months or as per manufacturer’s recommendation.

5.2 Monitoring Frequency

  1. Record ambient temperature and humidity:
    • Twice daily (e.g., 9:00 AM and 5:00 PM)
    • In Annexure-1: Ambient Condition Monitoring Log
  2. Acceptable ambient conditions:
    • Temperature: 18°C to 25°C
    • Relative Humidity (RH): 40% to 60%

5.3 Alarm and Alert System

  1. Set upper and lower alert limits in devices to notify staff in case of deviation.
  2. Ensure audio or SMS alerts are enabled for remote monitoring.
See also  BA-BE Studies: SOP for Filing Form 44 to CDSCO for BA/BE Studies - V 2.0

5.4 Deviation Handling

  1. In case of deviation:
    • Record in Annexure-2: Ambient Condition Deviation Log
    • Investigate cause and take immediate corrective action (e.g., adjust HVAC, limit access)
    • Inform QA and document CAPA

5.5 Preventive Maintenance

  1. Perform monthly checks of air circulation, vents, and calibration due dates of instruments.
  2. Document maintenance activities in Annexure-3: Preventive Maintenance Log.

6. Abbreviations

  • BA: Bioavailability
  • BE: Bioequivalence
  • HVAC: Heating, Ventilation and Air Conditioning
  • RH: Relative Humidity
  • QA: Quality Assurance

7. Documents

  1. Ambient Condition Monitoring Log – Annexure-1
  2. Ambient Condition Deviation Log – Annexure-2
  3. Preventive Maintenance Log – Annexure-3

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • US FDA Guidance on Storage Conditions
  • WHO TRS 961 Annex 9 – Good Storage Practice
See also  BA-BE Studies: SOP for Exit Examination of Volunteers - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Ambient Condition Monitoring Log

Date Time Temperature (°C) Humidity (%) Checked By Remarks
17/04/2025 09:00 22.1 45 Ravi Nair Normal

Annexure-2: Ambient Condition Deviation Log

Date Time Observed Value Limit Breached Corrective Action Reviewed By
16/04/2025 17:00 27.5°C Temp > 25°C HVAC serviced, air duct opened Dr. Arvind Shah

Annexure-3: Preventive Maintenance Log

Date Activity Performed By Remarks
10/04/2025 HVAC filter cleaning Maintenance Team Completed

Revision History:

Revision Date Revision No. Details Reason Approved By
10/01/2022 1.0 Initial version Operational SOP QA Head
17/04/2025 2.0 Added alarm triggers and preventive maintenance log Audit enhancement QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: Tablets: SOP for Reconciliation of Packaging Materials Post-Production – V 2.0
Next Post: API Manufacturing: SOP for Calibration of Storage Vessels – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version